STAAR Surgical (STAA) Tops Q4 EPS by 3c, Beats on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts STAA Hot Sheet
Price: $25.17 +0.92%
Revenue Growth %: -16.9%
Financial Fact:
Other income (expense), net: -68K
Today's EPS Names:
FUSE, INM, TRI, More
Revenue Growth %: -16.9%
Financial Fact:
Other income (expense), net: -68K
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
Note: EPS may not be comparable
STAAR Surgical (NASDAQ: STAA) reported Q4 EPS of $0.02, $0.03 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $24.9 million versus the consensus estimate of $23.96 million.
For earnings history and earnings-related data on STAAR Surgical (STAA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Comscore (SCOR) Misses Q3 EPS by 446c
- Ovintiv Inc. (OVV) Tops Q3 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
